ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/28/2024
Back to search
Official data from USPTO
SAGENT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SAGENT PHARMACEUTICALS
ST13
US500000078981049Class
5
Filing
78981049
Registration
3743423
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
73
Latest update
02/28/2024
Trademark type
Word
Nice classes
5
Filing date
04/21/2006
Registration date
01/26/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2020
Last transaction
03/21/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/28/2009
First use in commerce
10/28/2009
Drawing code
4
Owner type
03
Owner location
SCHAUMBURG, IL
Examiner
BROWNE, DAYNA
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
S. P. (pessoa física)
SAGENT PHARMACEUTICALS, INC.
SAGENT HOLDING CO.
New Hisun Inc
Representatives
Mark A. Paskar Bryan Cave Leighton Paisner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsanti-infectivescardiovascularsvascular targeting agents; Injectable drugs and therapeutic solutions for the treatment of vascular diseases; injectable drugs and therapeutic solutions for the treatment of allergies; injectable drugs and therapeutic solutions for the treatment of infections; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease
Publications
History of USPTO decisions and trademark events.
73 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/21/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/21/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/21/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/24/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/26/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/13/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/29/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/29/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2016
E815
TEAS SECTION 8 & 15 RECEIVED
07/26/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/15/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/05/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/22/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/17/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/23/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/23/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/23/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2009
GNRT
NON-FINAL ACTION E-MAILED
05/30/2009
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/30/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/27/2009
DPCC
DIVISIONAL PROCESSING COMPLETE
03/27/2009
EX2G
SOU EXTENSION 2 GRANTED
03/27/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/27/2009
IUAF
USE AMENDMENT FILED
03/06/2009
DRRR
DIVISIONAL REQUEST RECEIVED
03/06/2009
EXT2
SOU EXTENSION 2 FILED
03/06/2009
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/06/2009
EEXT
SOU TEAS EXTENSION RECEIVED
03/06/2009
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/04/2009
EX1G
SOU EXTENSION 1 GRANTED
10/29/2008
EXT1
SOU EXTENSION 1 FILED
10/29/2008
EEXT
SOU TEAS EXTENSION RECEIVED
10/29/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
04/29/2008
PUBO
PUBLISHED FOR OPPOSITION
02/05/2008
NPUB
NOTICE OF PUBLICATION
01/16/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/14/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/01/2007
ALIE
ASSIGNED TO LIE
12/01/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
10/26/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/26/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
10/26/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/26/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/14/2007
GNRT
NON-FINAL ACTION E-MAILED
08/14/2007
CNRT
NON-FINAL ACTION WRITTEN
08/14/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2007
GNRT
NON-FINAL ACTION E-MAILED
06/12/2007
CNRT
NON-FINAL ACTION WRITTEN
06/12/2007
PGOA
PETITION GRANTED - REMAIL OFFICE ACTION
06/11/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/07/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/07/2007
PETR
PETITION TO REVIVE-RECEIVED
05/07/2007
PAPER RECEIVED
05/07/2007
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/25/2007
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
04/25/2007
GNRT
NON-FINAL ACTION E-MAILED
09/27/2006
CNRT
NON-FINAL ACTION WRITTEN
09/27/2006
DOCK
ASSIGNED TO EXAMINER
09/25/2006
NWAP
NEW APPLICATION ENTERED
04/27/2006
Continuous trademark protection
Get notified about every new filing that threatens SAGENT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.